VIO Imaging for Skin Tissue Assessment (VISTA)

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

65 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-20

Study Completion Date

2023-08-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To demonstrate the safety and effectiveness of the VIO device in obtaining in vivo images that show tissue features including epidermis, dermis, collagen, blood vessels, and/or pigment.

To demonstrate that the tissue features identified on the images obtained with the VIO device align with the corresponding pathology images procured from the skin biopsy.

To evaluate the ability of blinded readers to correctly identify tissue features on images obtained with the VIO device.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin

NCT00588315

Skin Cancer

ACTIVE_NOT_RECRUITING

Early Detection of Skin Cancer With Sensor Technology

NCT02668614

Carcinoma, Basal Cell

COMPLETED NA

The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes

NCT06279143

BCC - Basal Cell Carcinoma BCC Skin Diseases +2 more

RECRUITING

Study to Examine Lesions of the Skin Using Confocal Laser Microscopy

NCT06598137

Benign Skin Tumor Basal Cell Carcinoma Melanoma +1 more

ACTIVE_NOT_RECRUITING

DermaSensor Study of Primary Care Physician Use of Elastic-Scattering Spectroscopy (ESS) on Skin Lesions Suggestive of Skin Cancer

NCT06690086

Skin Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Condition Skin Diseases Skin Lesion Skin Abnormalities Skin Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

VIO Imaging

Subjects with skin conditions that are candidates for biopsy

Group Type EXPERIMENTAL

VIO Imaging

Intervention Type DEVICE

Skin conditions that are candidates for skin biopsies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

VIO Imaging

Skin conditions that are candidates for skin biopsies

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The subject is between 18 and 99 years of age.
2. The subject or Legally Authorized Representative (LAR) is able and willing to provide written informed consent.
3. The subject is planning to undergo a routine skin biopsy.
4. The subject is willing and able to remain still for periods of up to 3 minutes to allow for image capture.
5. The subject or LAR has sufficient mental capacity to understand the informed consent form (ICF) and comply with the protocol requirements.

Exclusion Criteria

1. The subject has a general health condition or systemic disease that in the opinion of the physician, precludes them from trial participation.
2. The subject has a known allergy or increased skin sensitivity to silicone, adhesives, or glycerin.
3. The subject's lesion targeted for biopsy:

1. Is located on the palms of the hands, soles of the feet, fingernails, or toenails.
2. Has dense hair that will not be removed prior to the skin biopsy.
3. Has clinically significant abraded or ulcerated skin with or without discharge.
4. Is associated with a wound or skin condition that in the opinion of the physician precludes them from participation
5. Is located in mucosal tissue (i.e., oral, nasal, etc.).
6. Is on tattooed skin.
7. Is on a skin formation too tortuous for the investigational device to access (e.g., skin tags.)
8. Is located in the periorbital region or directly on the eyelid.

\-

Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No